dc.contributor.author | De Franco, E | |
dc.contributor.author | Saint‐Martin, C | |
dc.contributor.author | Brusgaard, K | |
dc.contributor.author | Knight Johnson, AE | |
dc.contributor.author | Aguilar‐Bryan, L | |
dc.contributor.author | Bowman, P | |
dc.contributor.author | Arnoux, J | |
dc.contributor.author | Rønholt Larsen, A | |
dc.contributor.author | Sanyoura, M | |
dc.contributor.author | Greeley, SAW | |
dc.contributor.author | Calzada‐León, R | |
dc.contributor.author | Harman, B | |
dc.contributor.author | Houghton, JAL | |
dc.contributor.author | Nishimura‐Meguro, E | |
dc.contributor.author | Laver, TW | |
dc.contributor.author | Ellard, S | |
dc.contributor.author | del Gaudio, D | |
dc.contributor.author | Thybo Christesen, H | |
dc.contributor.author | Bellanné‐Chantelot, C | |
dc.contributor.author | Flanagan, SE | |
dc.date.accessioned | 2020-02-14T09:29:47Z | |
dc.date.issued | 2020-02-06 | |
dc.description.abstract | The most common genetic cause of neonatal diabetes and hyperinsulinism are pathogenic variants in ABCC8 and KCNJ11. These genes encode the subunits of the beta‐cell ATP sensitive potassium channel, a key component of the glucose‐stimulated insulin secretion pathway. Mutations in the two genes cause dysregulated insulin secretion; inactivating mutations cause an over‐secretion of insulin leading to congenital hyperinsulinism, whilst activating mutations cause the opposing phenotype, diabetes. This review focuses on variants identified in ABCC8 and KCNJ11, the phenotypic spectrum and the treatment implications for individuals with pathogenic variants. | en_GB |
dc.description.sponsorship | Wellcome Trust | en_GB |
dc.description.sponsorship | Royal Society | en_GB |
dc.description.sponsorship | Diabetes UK | en_GB |
dc.description.sponsorship | National Institutes of Health (NIH) | en_GB |
dc.description.sponsorship | American Diabetes Association | en_GB |
dc.description.sponsorship | Kovler Family Foundation | en_GB |
dc.identifier.citation | Published online 6 February 2020 | en_GB |
dc.identifier.doi | 10.1002/humu.23995 | |
dc.identifier.grantnumber | 105636/Z/14/Z | en_GB |
dc.identifier.grantnumber | 16/0005407 | en_GB |
dc.identifier.grantnumber | P30 DK020595 | en_GB |
dc.identifier.grantnumber | K23 DK094866 | en_GB |
dc.identifier.grantnumber | R03 DK103096 | en_GB |
dc.identifier.grantnumber | R01 DK104942 | en_GB |
dc.identifier.grantnumber | UL1 TR000430 | en_GB |
dc.identifier.grantnumber | 1-11-CT-41 | en_GB |
dc.identifier.grantnumber | 1-17-JDF-008 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/40860 | |
dc.language.iso | en | en_GB |
dc.publisher | Wiley for Human Genome Variation Society | en_GB |
dc.rights.embargoreason | Under embargo until 6 February 2021 in compliance with publisher policy. | en_GB |
dc.rights | © 2020 Wiley | en_GB |
dc.subject | Neonatal Diabetes | en_GB |
dc.subject | Congenital Hyperinsulinism | en_GB |
dc.subject | ABCC8 | en_GB |
dc.subject | KCNJ11 | en_GB |
dc.subject | K-ATP channel | en_GB |
dc.title | Update of variants identified in the pancreatic beta‐cell K ATP channel genes KCNJ11 and ABCC8 in individuals with congenital hyperinsulinism and diabetes | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2020-02-14T09:29:47Z | |
dc.identifier.issn | 1059-7794 | |
exeter.article-number | humu.23995 | en_GB |
dc.description | This is the author accepted manuscript. The final version is available from Wiley via the DOI in this record | en_GB |
dc.identifier.journal | Human Mutation | en_GB |
dc.rights.uri | http://www.rioxx.net/licenses/all-rights-reserved | en_GB |
exeter.funder | ::Wellcome Trust | en_GB |
exeter.funder | ::Wellcome Trust | en_GB |
rioxxterms.version | AM | en_GB |
rioxxterms.licenseref.startdate | 2020-02-06 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2020-02-14T09:24:45Z | |
refterms.versionFCD | AM | |
refterms.panel | A | en_GB |